News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

WuXi PharmaTech Co., Ltd. Teams Up With PRA International, Inc. (PRAI) to Form Clinical JV


12/19/2012 11:06:31 AM

by Richard Daverman, PhD

December 18, 2012 -- WuXi PharmaTech, a CRO known mostly for its pre-clinical services is forming a JV with PRA, a US-based clinical-stage CRO. The JV will offer Phase I-IV clinical trial management and related services in China, Hong Kong and Macau. WuXi entered the clinical sphere in a small way one year ago by buying MedKey Med-Tech Development, a CRO located in China. But the company seems to have wanted a bigger presence on the clinical side, a presence that would be closer to its eminent stature in the pre-clinical market More details....

Stock Symbol: (NYSE: WX)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES